Amongst 30 million Americans diagnosed with diabetes, about 1.4 million Type-1 Diabetes patients require insulin lifelong to manage their condition, but affordability is a great concern. Insulin prices have increased up to 1200% since 1996, even though the formulations have largely remained the same. The cost of insulins is ten times more in the USA than in any other developed country.